IR
46
3
FTI
61
5
FOX
71
3
MS
64
3
CA
19
6
AIG
38
5
SHW
42
5
IRM
33
5
DRI
74
5
APH
53
3
VIX
41
-11
PRU
39
3
TMO
52
8
BAC
38
3
ETN
64
4
EBAY
42
2
GT
43
2
JNPR
59
3
ICE
53
5
OMC
37
2
IR
46
3
FTI
61
5
FOX
71
3
MS
64
3
CA
19
6
AIG
38
5
SHW
42
5
IRM
33
5
DRI
74
5
APH
53
3
VIX
41
-11
PRU
39
3
TMO
52
8
BAC
38
3
ETN
64
4
EBAY
42
2
GT
43
2
JNPR
59
3
ICE
53
5
OMC
37
2
Financhill
Back

Janux Therapeutics 10K Form

Sell
28

JANX
Janux Therapeutics

Last Price:
$56.16
Seasonality Move:
84.76%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive JANX News And Ratings

See the #1 stock for the next 7 days that we like better than JANX

JANX Financial Statistics

Sales & Book Value

Annual Sales: $8.1M
Cash Flow: $-2.3M
Price / Cash Flow: 0
Annual Sales: $12.54
Price / Book: 4.54

Profitability

EPS (TTM): -1.16000
Net Income (TTM): $-60.5M
Gross Margin: --
Return on Equity: -11.37%
Return on Assets: -10.65%

Janux Therapeutics Earnings Forecast

Key Janux Therapeutics Financial Ratios

  • The Research & Development expenses have been 679.48% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of JANX is -721.18% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 2 years.

Janux Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: JANX
Website: januxrx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 38.8
Quick Ratio: 38.58

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

JANX Technical Analysis vs Fundamental Analysis

Sell
28
Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics a Buy or a Sell?